What are the advantages of Wetech s continuous glucose monitoring system compared with traditional b

First of all, I will tell you about the situation of insulin pumps, which are composed of a pump, a small syringe and an infusion tube connected to it. The small syringe can hold up to 3 ml of insulin, after the syringe is loaded into the pump, the guide needle at the front end of the connected infusion tube is inserted into the patient's subcutaneous (usually the abdominal wall) with a syringe, and then the screw motor of the battery-driven insulin pump pushes the piston of the small syringe, and the basic purpose of insulin infusion into the body is to simulate the secretion function of the pancreas, and continuously inject insulin into the user's subcutaneous according to the dose required by the human body, so as to maintain blood sugar stability throughout the day to achieve the purpose of controlling diabetes.

Kailianle pump is this more traditional insulin pump, Weitai is the insulin pump that cancels the pipeline, it is a little smaller, the volume is half the size of the insulin pump of Kailianle pump, that is, the concealment is better than the price, but ** is twice that of Kailianle pump, and the cost of consumables is also more expensive, after all, people are half-thrown products, but Kailianle pump insulin pump is more stable, so girls who love beauty can consider a smaller one, and the old man or the size is not too concerned about the size or use the Kailianle pump steadily.

Compared with traditional blood glucose monitoring systems, AIDEX G7 has the advantages of real-time monitoring, no need for repeated fingerstick blood collection, and reduced risk of hyperhypoglycemia.

Wetech's AIDEX continuous glucose monitoring system is a very forward-looking product in the field of diabetes monitoring. In recent years, the clinical value of CGM has gradually been recognized by diabetes guidelines at home and abroad, and the scope and frequency of its use have increased dramatically. CGM is also recommended as the gold standard for insulin-intensive** blood glucose monitoring in diabetic patients.

The dynamics of Weitai Medical are worth looking forward to.

And it's good to be able to use that grapevine pepper, a way for him to record the main way in the system, and then change its overall operation by yourself.

What is a continuous glucose monitoring system? This specific need is only known to him when he obtains this aspect of the test.

Is glucose monitoring necessary for monitoring Is it necessary for him to monitor it in the hospital? Then you have to ask the sales rep.

It's worth it, after all, the prospect of Weitai Medical is quite good.

Weitai Medical-B (02235) announced that the company issued 10,000 shares. The issue price per share is HK$ (the same as below).

Assuming that the over-allotment option is not exercised, the net proceeds will be $100 million. It is 100 shares per board lot and is expected to be listed on October 19. The company's public offering was doubled.

The final number of Offer Shares under the Public Offer is 10,000 shares, representing approximately 10% of the total number of Offer Shares (before any over-allotment option is exercised).

In addition, the final number of Offer Shares under the International Offering is 10,000 shares, representing approximately 90% of the total number of Offer Shares (before any over-allotment option is exercised).

Founded in 2011, Weitai Medical is mainly engaged in the R&D and production of diabetes** and diabetes monitoring medical devices.

At present, Weitai Medical has three products on sale, namely: EQUIL patch insulin pump, which has been launched in China and the European Union; AIDEX G7 continuous glucose monitoring system, only available in the EU; IVD blood glucose monitoring system products have been launched in China, the United States and the European Union. Financial data show that in 2019 and 2020, Weitai Medical recorded revenue of 10,000 yuan and 10,000 yuan respectively; recorded a net loss of 10,000,000,000 yuan and 100,000 In the first four months of 2021, the company achieved revenue of 10,000 yuan and a net loss of 10,000 yuan.

Although three products have been listed, including the core product equil, Wetech Medical's losses are still further expanding. The loss of nearly 200 million yuan in two years was mainly due to the company's rising administrative expenses, research and development expenses, sales and distribution expenses during the reporting period.

Wetech is the only company in the world that has both an approved patch insulin pump and a calibration-free continuous glucose monitoring system.

In 2019 and 2020, the proportion of EQUIL product revenue to the company's total revenue showed a slight downward trend, respectively; The blood glucose monitoring system revenue accounts for a larger portion of the total revenue.

Extended information: At present, there are two main types of insulin pumps on the market: tubal insulin pumps and patch insulin pumps.

Compared to traditional tubal insulin pumps, tubeless patch insulin pumps do not have a catheter, which can avoid many of the problems caused by catheters, and the device is smaller and more portable.

The main disadvantage is that it is expensive, in China, the average daily cost of patients using EQUIL is about 32 to 36 yuan, while the average daily cost of patients using traditional insulin syringes or insulin pens is only about 7 yuan to 10 yuan. It is not difficult to understand that traditional diabetes** devices still occupy the majority of the market share.

In terms of the industry, the demand for diabetes medical devices may continue unabated. According to the data, the number of people with diabetes in China was 100 million in 2019 and is expected to reach 100 million by 2030. The market size of diabetes medical devices in China is expected to increase from US$900 million in 2020 to US$3.6 billion in 2030, with a compound annual growth rate.

My grandmother used to be hospitalized before, the Leyland continuous blood glucose monitoring system, which is relatively good.

Prevention and Treatment of Diabetes North July 19, 2013 10:58:30.

There are two main methods of blood glucose monitoring commonly used, one is fingertip blood capillary blood glucose, and the other is continuous glucose monitoring (CGM). Fingerstick blood capillary blood glucose monitoring is fingerstick blood collection, the advantage is that it is more economical, the disadvantage is that the experience is poor, the accuracy is low, and the requirements for blood collection time are relatively strict, so now in terms of technology, the second type is generally used, that is, continuous blood glucose monitoring.

The examination methods and monitoring methods of diabetes patients need to understand that the examination methods are mainly to measure blood glucose, glycosylated hemoglobin, pancreatic islet function, and blood sugar including fasting blood glucose and postprandial blood glucose, which is an indicator for diagnosing diabetes and an important indicator for detecting whether blood sugar control is up to standard. Glycosylated hemoglobin is an assessment of the three-month average blood sugar level and needs to be measured every three months. The function of pancreatic islets includes insulin and C-peptide, which reflects whether the islets can be secreted.

Urinalysis is also needed to determine the level of glucose and protein in the urine. Blood glucose monitoring mainly relies on self-glucose monitoring, usually measuring finger capillary blood glucose, and patients with conditions can install continuous blood glucose monitoring, that is, synapsing, which can be installed every two weeks, and can see the fluctuation of blood sugar at all times.

Blood glucose monitoring is a regular check of blood glucose levels. The implementation of blood glucose monitoring can better control the blood sugar changes of diabetic patients, which has important guiding significance for daily routine, activity, exercise, diet and rational medication, and can help patients find problems at any time and seek medical treatment in time.

The blood glucose detection system is a technology that implants a glucose sensor under the skin and indirectly reflects the blood glucose level by monitoring the glucose concentration in the subcutaneous interstitial fluid, and can continuously and dynamically detect blood sugar changes. The system checks and records blood glucose data in daily life, automatically records blood glucose data every few minutes, and can monitor dynamic blood glucose changes within 72 hours at the shortest, and the current more advanced Freesun libre glucose monitoring system can achieve 14 days of continuous continuous glucose monitoring, and draw an accurate daily blood glucose change curve, marked with diet, exercise and other events on the curve.

Through the continuous glucose monitoring system, it can provide important clues for timely clinical diagnosis and reasonable detection, and find occult hyperglycemia and hypoglycemia that are not easy to be detected by traditional monitoring methods, especially postprandial hyperglycemia and nocturnal asymptomatic hypoglycemia, twilight phenomenon, dawn phenomenon, etc., to help doctors develop individualized plans for patients, and to provide patients with visualization means for diabetes education, so as to improve the compliance of patients.

Glycated serum protein (GSP).

Glucose in the blood undergoes a non-enzymatic glycation reaction with albumin and other protein molecules at the end of the molecule n to form glycosylated serum proteins. It takes about 7 days for the formation of glycosylated serum protein, while the half-life of albumin in serum is about 21 days, and the glycosylated serum protein assay can effectively reflect the average blood glucose level of patients in the past 2 to 3 weeks. As a sensitive indicator of short-term control of diabetes, it can get the best effect feedback in the short term, especially as a short-term blood glucose monitoring indicator for gestational diabetes or pregnant patients with diabetes.

There are many types of blood glucose monitoring for diabetes, the first is fasting blood glucose, the second is random blood sugar, and then what? There is also blood sugar after dismantling, etc.

Diabetes mellitus** must be premised on diet control and exercise**. Diabetic patients should avoid sugary and sugary foods, reduce the intake of high-fat and high-cholesterol foods, eat high-fibre and starchy foods in moderation, and eat small and frequent meals. Exercise should be chosen under the guidance of a physician, and whole-body exercise, including walking and jogging, should be done whenever possible.

On this basis, appropriate insulin sensitizers or other hypoglycemic drugs can be used to achieve the purpose of long-term effective blood sugar control. However, oral medication is not good or appropriate use of insulin, eating more bitter gourd has a good auxiliary hypoglycemic effect, do a good job of daily personal blood glucose monitoring and adjust medication to avoid complications, blood glucose monitoring can be used with a home portable blood glucose meter.

Diabetic patients should regularly monitor fasting blood glucose, 2-hour postprandial blood glucose, glycosylated hemoglobin, and if blood glucose fluctuates greatly, continuous glucose monitoring is required. Attention should be paid to the following points in blood glucose monitoring:1

Diabetic patients not only need to monitor fasting blood glucose, but also need to monitor blood glucose 2 hours after meals at the same time, understand the patient's blood sugar fluctuations, and guide the application of hypoglycemic drugs. 2.Glycosylated hemoglobin is monitored every 2-3 months, and glycosylated hemoglobin is the gold standard for glycemic control to guide the selection of hypoglycemic drugs.

3.Diabetic patients with hypoglycemia such as palpitation, sweating, hand tremors, and fatigue should monitor random blood glucose in time to understand whether hypoglycemia occurs. 4.

For patients with high fasting blood glucose and hypoglycemic reaction at night, blood glucose should be measured at 3 a.m. at night to understand whether there is nocturnal hypoglycemia and guide the application of hypoglycemic drugs.

In 1999, the U.S. Food and Drug Administration approved the world's first continuous glucose monitoring system. This system can record the blood glucose value within three days, and then the medical staff can send the data to the computer for analysis and issue a three-day continuous blood sugar report. This system is used to establish a patient's all-day blood glucose profile to guide initial and monitoring.

There is no need, choose a good time to order 0 hours, 1 hour, 2 hours, 2 o'clock at night to measure 4 times a day, it is enough, it is not painful, the progress of the instrument marks the regression of the doctor's technology, and it is not a legend that Chinese medicine takes the pulse to see a doctor, what instrument is used.

A glucose oxidase reaction is used to monitor the concentration of sugar content in human tissue fluids. From this, blood glucose values are derived. There is a delay of about 5-30 minutes (depending on the individual's circulatory speed) from the actual fingerstick whole blood glucose.

It's a very friendly technique for sugar people, and you don't need to prick your fingers many times a day during the adjustment period. I am using Yee Jian myself, and it is very convenient and intuitive to check my blood sugar, and other peripheral functions such as remote monitoring are also perfect. If you need to, you can find out.

Pure sugar friends share.